The following is a summary of “Mendelian randomization of plasma proteomics identifies novel ALS-associated proteins and their GO enrichment and KEGG pathway analyses,” published in the March 2025 ...
.Key Drivers: Rising ALS prevalence, increasing awareness, and advancements in drug development. .Challenges: Limited treatment options, delayed diagnosis, and drug side effects. Get a Sample Copy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback